Cord Blood America, Inc. (CBAI.OB), the umbilical cord blood stem cell preservation company, reports revenues for 2006 topped $3.89 million, up 71 percent compared to revenues of $2.28 million in 2005.
The Company posted a gross profit of $703,933 in 2006, up 37 percent compared to $513,340 in the previous year. The loss from operations decreased significantly in 2006, as the company recorded a $2. 1 million interest expense, more than 35% of the loss.
“The results we are posting, we believe, will be recognized as a significant achievement by both the financial markets and by investors,” said Matthew Schissler, CEO. “We are extremely encouraged by our 2006 financial results.”
Let us hear your thoughts below:
